These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 35949146)
1. Single pot organic solvent-free thermocycling technology for siRNA-ionizable LNPs: a proof-of-concept approach for alternative to microfluidics. De A; Ko YT Drug Deliv; 2022 Dec; 29(1):2644-2657. PubMed ID: 35949146 [TBL] [Abstract][Full Text] [Related]
2. A tale of nucleic acid-ionizable lipid nanoparticles: Design and manufacturing technology and advancement. De A; Ko YT Expert Opin Drug Deliv; 2023 Jan; 20(1):75-91. PubMed ID: 36445261 [TBL] [Abstract][Full Text] [Related]
3. Why mRNA-ionizable LNPs formulations are so short-lived: causes and way-out. De A; Ko YT Expert Opin Drug Deliv; 2023 Feb; 20(2):175-187. PubMed ID: 36588456 [TBL] [Abstract][Full Text] [Related]
4. Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform. Bailey-Hytholt CM; Ghosh P; Dugas J; Zarraga IE; Bandekar A J Vis Exp; 2021 Feb; (168):. PubMed ID: 33720139 [TBL] [Abstract][Full Text] [Related]
5. Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery. Kimura N; Maeki M; Sato Y; Ishida A; Tani H; Harashima H; Tokeshi M ACS Appl Mater Interfaces; 2020 Jul; 12(30):34011-34020. PubMed ID: 32667806 [TBL] [Abstract][Full Text] [Related]
7. Characterization of Lipid Nanoparticles Containing Ionizable Cationic Lipids Using Design-of-Experiments Approach. Terada T; Kulkarni JA; Huynh A; Chen S; van der Meel R; Tam YYC; Cullis PR Langmuir; 2021 Jan; 37(3):1120-1128. PubMed ID: 33439022 [TBL] [Abstract][Full Text] [Related]
8. Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions. Reinhart AG; Osterwald A; Ringler P; Leiser Y; Lauer ME; Martin RE; Ullmer C; Schumacher F; Korn C; Keller M Mol Pharm; 2023 Dec; 20(12):6492-6503. PubMed ID: 37975733 [TBL] [Abstract][Full Text] [Related]
9. Impact of non-ionizable lipids and phase mixing methods on structural properties of lipid nanoparticle formulations. Pratsinis A; Fan Y; Portmann M; Hammel M; Kou P; Sarode A; Ringler P; Kovacik L; Lauer ME; Lamerz J; Hura GL; Yen CW; Keller M Int J Pharm; 2023 Apr; 637():122874. PubMed ID: 36948476 [TBL] [Abstract][Full Text] [Related]
11. On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA. Kulkarni JA; Darjuan MM; Mercer JE; Chen S; van der Meel R; Thewalt JL; Tam YYC; Cullis PR ACS Nano; 2018 May; 12(5):4787-4795. PubMed ID: 29614232 [TBL] [Abstract][Full Text] [Related]
12. Single-step microfluidic synthesis of transferrin-conjugated lipid nanoparticles for siRNA delivery. Li Y; Lee RJ; Huang X; Li Y; Lv B; Wang T; Qi Y; Hao F; Lu J; Meng Q; Teng L; Zhou Y; Xie J; Teng L Nanomedicine; 2017 Feb; 13(2):371-381. PubMed ID: 27720989 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of Polymer-Lipid Nanoparticles by Microfluidic Focusing for siRNA Delivery. Li Y; Huang X; Lee RJ; Qi Y; Wang K; Hao F; Zhang Y; Lu J; Meng Q; Li S; Xie J; Teng L Molecules; 2016 Oct; 21(10):. PubMed ID: 27763492 [TBL] [Abstract][Full Text] [Related]
15. Chemistry of Lipid Nanoparticles for RNA Delivery. Eygeris Y; Gupta M; Kim J; Sahay G Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635 [TBL] [Abstract][Full Text] [Related]
16. NMR-based analysis of impact of siRNA mixing conditions on internal structure of siRNA-loaded LNP. Ueda K; Sakagawa Y; Saito T; Sakuma F; Tanaka H; Akita H; Higashi K; Moribe K J Control Release; 2024 Sep; 373():738-748. PubMed ID: 39053648 [TBL] [Abstract][Full Text] [Related]
17. Structure, activity and uptake mechanism of siRNA-lipid nanoparticles with an asymmetric ionizable lipid. Suzuki Y; Ishihara H Int J Pharm; 2016 Aug; 510(1):350-8. PubMed ID: 27374199 [TBL] [Abstract][Full Text] [Related]
18. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics. Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715 [TBL] [Abstract][Full Text] [Related]
19. Hydrophobic scaffolds of pH-sensitive cationic lipids contribute to miscibility with phospholipids and improve the efficiency of delivering short interfering RNA by small-sized lipid nanoparticles. Sato Y; Okabe N; Note Y; Hashiba K; Maeki M; Tokeshi M; Harashima H Acta Biomater; 2020 Jan; 102():341-350. PubMed ID: 31733331 [TBL] [Abstract][Full Text] [Related]